ClinicalTrials.gg
Not yet recruitingNCT05936918Updated Jul 10, 2023

Application of Transcutaneous Electrical Acupoint Stimulation in Laparoscopic Cholecystectomy

An interventional study of Transcutaneous electrical acupoint stimulatios and Bilateral transverse abdominal plane block in Pain Postoperative and Postoperative Recovery, sponsored by Yangzhou University. Not yet recruiting. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-07-10.

Sponsored by Yangzhou University · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by Oct 2023, 3 years ago, but the record still lists the study as not yet recruiting.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
120
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

To explore the application of transcutaneous electrical acupoint stimulation combined with transverse abdominis plane block in Laparoscopic cholecystectomy, in order to reduce postoperative pain and promote postoperative recovery.

Read the detailed description

Percutaneous electrical acupoint stimulation has been applied in preoperative prophylaxis, intraoperative anesthesia and postoperative rehabilitation, and can reduce perioperative anxiety, improve the efficacy of preoperative smoking cessation and alcohol abstinence, and shorten the preoperative fasting time. During surgery, it can reduce the amount of anesthetic drugs, anti-inflammatory and anti-stress effects, stabilize circulation, and protect important organs; After surgery, improve the speed and quality of wake-up of patients, promote the recovery of maintenance function, regulate immune function, and reduce postoperative adverse reactions such as postoperative pain, postoperative nausea and vomiting, postoperative urinary retention, etc. As one of the common nerve blocks, transverse abdominis block is used clinically, and its main function is to relieve perioperative pain and reduce the amount of traumatic stress and analgesic drugs

02

Conditions studied

  • Pain Postoperative
  • Postoperative Recovery

Keywords

  • Transcutaneous electrical acupoint stimulation
  • Postoperative pain
  • Visceral pain
  • Early recovery after surgery
03

In context

Pain, Postoperative

5,680 studies on the registry are indexed under Pain, Postoperative; 1,243 are open to participants now.

This study's planned enrollment of 120 is above the median of 75 across 4,859 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

Yangzhou University is the lead sponsor of 41 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • (ASA) class I and II
  • Age 18-65 years
  • Laparoscopic cholecystectomy for the first time
  • There is no rupture, infection in the acupoint pasting site
  • The patient knows and signs the form

Exclusion criteria

Exclusion Criteria:

  • People with visual impairment, hearing impairment and alcoholism
  • History of diabetes, myocardial infarction or cerebrovascular accident, liver and kidney dysfunction
  • Those who are allergic to non-steroidal drugs, anticholinergic drugs, and anesthetic drugs
  • Those who are unable to cooperate or refuse to participate in the research or request to withdraw during the research process
  • Those with to percutaneous electrical stimulation, including local skin damage, infection or implantation of electrophysiological devices in the body
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

ASA physical status

The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
120 participants (estimated)

Study arms

  • Experimental
    TT group

    Bilateral Neiguan acupuncture points (PC6), Hegu acupuncture points (LI4), Zusanli (ST36) were selected, and percutaneous acupuncture points were electrically stimulated with electronic acupuncture equipment 30min before anesthesia, and then bilateral abdominal transverse plane blockade was performed

    Other: Transcutaneous electrical acupoint stimulatios · Other: Bilateral transverse abdominal plane block

  • Active comparator
    TE group

    Bilateral Neiguan acupuncture points (PC6), Hegu acupuncture points (LI4), Zusanli (ST36) were selected, and percutaneous acupuncture points were electrically stimulated with electronic acupuncture equipment 30min before anesthesia

    Other: Transcutaneous electrical acupoint stimulatios

  • Active comparator
    TA group

    Bilateral transverse abdominal plane block is performed prior to anesthesia

    Other: Bilateral transverse abdominal plane block

  • No intervention
    C group

    Percutaneous electrical stimulation of acupoints and transverse abdominis plane block are not permitted before anesthesia

Interventions

  • OtherTranscutaneous electrical acupoint stimulatios

    Percutaneous electrical stimulation technology of acupuncture points is a technology that uses a trace current close to human bioelectricity on the surface of acupuncture points to prevent and treat diseases guided by meridian theory, and is a new treatment of percutaneous nerve electrical stimulation combined with acupuncture points. As one of the related techniques of acupuncture, it is a safe, non-invasive, simple and new acupoint stimulation method

  • OtherBilateral transverse abdominal plane block

    Transverse abdominis plane block is a technique in which a local anesthetic is injected into the transverse abdominis plane to block sensory nerves passing through this plane to achieve analgesic effect

06

What researchers measure

Primary outcomes

  1. VAS(visual analogue scale) score

    Postoperative pain is assessed after surgery by using visual analogue scoring. A score to assess pain, use a swimming ruler about 10 cm long, marked with 10 scales on one side, with "0" and "10" ends at each end, 0 points means no pain, and 10 points represent the most severe pain that is unbearable.

    Time frame: The day before surgery

  2. VAS(visual analogue scale) score

    Postoperative pain is assessed after surgery by using visual analogue scoring. A score to assess pain, use a swimming ruler about 10 cm long, marked with 10 scales on one side, with "0" and "10" ends at each end, 0 points means no pain, and 10 points represent the most severe pain that is unbearable.

    Time frame: After the operation 30minute

  3. VAS(visual analogue scale) score

    Postoperative pain is assessed after surgery by using visual analogue scoring. A score to assess pain, use a swimming ruler about 10 cm long, marked with 10 scales on one side, with "0" and "10" ends at each end, 0 points means no pain, and 10 points represent the most severe pain that is unbearable.

    Time frame: After the operation 6hour

  4. VAS(visual analogue scale) score

    Postoperative pain is assessed after surgery by using visual analogue scoring. A score to assess pain, use a swimming ruler about 10 cm long, marked with 10 scales on one side, with "0" and "10" ends at each end, 0 points means no pain, and 10 points represent the most severe pain that is unbearable.

    Time frame: After the operation 12hour

  5. VAS(visual analogue scale) score

    Postoperative pain is assessed after surgery by using visual analogue scoring. A score to assess pain, use a swimming ruler about 10 cm long, marked with 10 scales on one side, with "0" and "10" ends at each end, 0 points means no pain, and 10 points represent the most severe pain that is unbearable.

    Time frame: After the operation 24hour

  6. VAS(visual analogue scale) score

    Postoperative pain is assessed after surgery by using visual analogue scoring. A score to assess pain, use a swimming ruler about 10 cm long, marked with 10 scales on one side, with "0" and "10" ends at each end, 0 points means no pain, and 10 points represent the most severe pain that is unbearable.

    Time frame: After the operation 48hour

Secondary outcomes

  1. Postoperative nausea and vomiting

    After surgery, patients are asked about nausea and vomiting. Postoperative nausea and vomiting is assessed after surgery by using visual analogue scoring. Using a swimming ruler about 10 cm long, marked with 10 scales on one side, with "0" and "10" ends at each end, 0 points means no nausea and vomiting, and 10 points represent the most severe nausea and vomiting that is unbearable.

    Time frame: The day before surgery; After the operation 24hours, 48hours

  2. Early postoperative recovery of quality

    The quality of early postoperative recovery was assessed using The Quality of Recovery-15 scale after surgery, scores range from 0 (QoR very poor) to 150 (QoR excellent), with higher scores representing better quality of recovery

    Time frame: The day before surgery; After the operation 24hours, 48hours

  3. Exhaust and bowel movements

    Record the time of the patient's first exhaust bowel movement after surgery

    Time frame: After the operation 24hours, 48hours

  4. Concentration of serum interleukin-6

    Perioperative venous blood was drawn to detect serum interleukin-6

    Time frame: the day before surgery; When entering the operating room; 10minutes after peeling; 5 minutes after the operation; The first day after surgery

  5. Concentration of serum cortisol

    Perioperative venous blood was drawn to detect serum cortisol

    Time frame: the day before surgery; When entering the operating room; 10minutes after peeling; 5 minutes after the operation; The first day after surgery

  6. Concentration of serum C-reactive protein

    Perioperative venous blood was drawn to detect serum C-reactive protein

    Time frame: the day before surgery; When entering the operating room; 10minutes after peeling; 5 minutes after the operation; The first day after surgery

07

Study locations

No study locations are listed for this record.

08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2023; primary completion for Oct 2023, 3 months later.

Of 2,113 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 3 months is below that.

Counting every sponsor, half of 2,126 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 6, 2023
First posted
Jul 10, 2023
StartEst.
Jul 2, 2023
Primary completionEst.
Oct 31, 2023
CompletionEst.
Dec 31, 2023
Last update
Jul 10, 2023
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jul 10, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT05936918
Lead sponsor
Yangzhou University
Responsible party
Wang wanxia (Principal Investigator, Yangzhou University) — Principal investigator
First posted
Jul 10, 2023
Start date
Jul 2, 2023 (estimated)
Primary completion
Oct 31, 2023 (estimated)
Completion
Dec 31, 2023 (estimated)
Last update
Jul 10, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion